1989
DOI: 10.1016/0002-8703(89)90848-x
|View full text |Cite
|
Sign up to set email alerts
|

Amlodipine versus nadolol in patients with stable angina pectoris

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
7
0

Year Published

1992
1992
2012
2012

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…Almost all of the cited substances have an established capacity either to directly induce coronary vasoconstriction or to favor platelet aggregation and thrombosis (3). In our patient, the vasoconstrictive action of these substances may have been enhanced by the lack of the protective counterbalancing vasodilatator effect of amlodipine, a calcium channel blocker with known coronary vasodilatation action that was withdrawn several weeks before the incident (7). This is of particular interest considering the fact that the patient reported having been previously stung by wasps in the same geographic region (assuming it was the same species) but without developing any particular reaction.…”
Section: Discussionmentioning
confidence: 87%
“…Almost all of the cited substances have an established capacity either to directly induce coronary vasoconstriction or to favor platelet aggregation and thrombosis (3). In our patient, the vasoconstrictive action of these substances may have been enhanced by the lack of the protective counterbalancing vasodilatator effect of amlodipine, a calcium channel blocker with known coronary vasodilatation action that was withdrawn several weeks before the incident (7). This is of particular interest considering the fact that the patient reported having been previously stung by wasps in the same geographic region (assuming it was the same species) but without developing any particular reaction.…”
Section: Discussionmentioning
confidence: 87%
“…Many reports have indicated that PRP at termination of exercise and at the same exercise time did not exceed and, in fact was slightly lower than, the correponding parameters measured during the observation period [7,11,12]. Therefore, the antianginal effect of amlodipine appears to arise from an inhibitory action upon myocardial oxygen consumption rather than an increase in coronary blood flow.…”
Section: Discussionmentioning
confidence: 95%
“…Jackson et al [6] reported that on the seventh day of administration of single daily doses of 2.5-10 mg of amlodipine, the exercise time of patients with exertional angina was significantly prolonged, indicating that efficacy is manifested from an early date in the regimen. However, most reports indicate that at least 4 weeks of administration are required in order to properly assess improvement with respect to number of anginal attacks and exercise tolerance [7,[9][10][11][12]. In one study, patients with exertional angina were divided into four groups, receiving single daily doses of 1.25, 2.5, 5, and 10 mg of amlodipine; exercise tests were conducted on the 24th hour after 4 weeks of administration and the results indicated that exercise time was significantly prolonged in the groups receiving 5-and 10-mg doses, as well as verifying that the antianginal action of amlodipine was sustained for 24 hours [10]; the effective 5-mg doses were associated with a peak blood concentration of 6.3 + 0.7 ng/ml on the 14th day of administration [15].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations